ANVS 9.21 (+6.35%)
US03615A1088BiotechnologyBiotechnology

Annovis Bio (ANVS) Financial Metrics

This table shows a selected set of financial data points of Annovis Bio (ANVS). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -6.23 0 -3 168.73M 0 0 -39.97M -33.2M -56.2M 5.75M
2022 -3.1 0 -4.33 109.62M 0 0 -17.31M -25.51M -25.33M 28.38M
2021 -1.9 0 -9.25 134.07M -0.54 0 -9.13M -14.5M -14.49M 45.69M
2020 -0.87 0 -8.71 47.57M -1.18 0 -3.97M -5.46M -5.46M 8.07M
2019 -0.17 0 0 0 -1.7 0 -476.54K -791.05K -990.98K 1.86K
2018 -0.16 0 0 0 -3.49 0 -558.61K -713.81K -713.87K 35.31K
2017 -0.16 0 0 0 -0.43 0 -537.48K -682.27K -682.35K 347.47K
2012 0 0 0 0 -0.7 185.18K 0 0 -8.32M 72.32K
2011 0 0 0 0 -0.22 0 0 0 -4.73M 1.39M
2010 0 0 0 0 -0.11 7.17M 0 0 -1.32M 4.4M
2009 0 0 0 0 0 15.72K 0 0 -369.58K 31.76K

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.